6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03652870 (ClinicalTrials.gov)	November 1, 2019	8/8/2018	Antidepressants Trial in Parkinson's Disease	A Randomised Placebo-Controlled Trial of Escitalopram and NortriptylineWith Standard Psychological C ...	Depression;Parkinson Disease	Drug: Nortriptyline;Drug: Escitalopram;Drug: Placebo	University College, London	London North West Healthcare NHS Trust;King's College London;University Hospital Plymouth NHS Trust; ...	Not yet recruiting	18 Years	85 Years	All	408	Phase 3	NULL
2	EUCTR2018-002942-35-GB (EUCTR)	31/10/2019	05/09/2019	A Randomised Controlled Trial of Escitalopram and Nortriptylinecompared with placebo, and standard p ...	A Randomised Controlled Trial of Escitalopram and Nortriptylinecompared with placebo and standard ps ...	Depression in Parkinson's disease MedDRA version: 20.0;Level: PT;Classification code 10012378;Term: ...	Product Name: Escitalopram INN or Proposed INN: Escitalopram oxalate Trade Name: Nortriptyline Product N ...	University College London Comprehensive Clinical Trials Unit	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	408	Phase 3	United Kingdom
3	NCT00062738 (ClinicalTrials.gov)	June 2003	12/6/2003	Treatment of Depression in Parkinson's Disease Trial	Treatment of Depression in Patients With Parkinson's Disease	Parkinson Disease;Depression	Drug: paroxetine;Drug: Nortriptyline;Other: placebo	Rutgers, The State University of New Jersey	GlaxoSmithKline	Completed	35 Years	80 Years	All	52	Phase 2	United States

First Previous1Next Last